We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Johnson & Johnson has announced that it will begin evaluating its experimental COVID-19 vaccine in its first clinical trial next week, beginning in Belgium on July 22 and the U.S. the following week. Read More
As research on COVID-19 vaccines advances at an unprecedented pace, Russian hackers have been attempting to steal research information, the UK’s National Cyber Security Centre (NCSC) reported Thursday. Read More
The FDA said yesterday that it has reviewed more than 230 clinical trials of potential COVID-19 treatments so far through its Coronavirus Treatment Acceleration Program (CTAP). Read More
Senate Democrats are calling on Congress for $25 billion in emergency funding to support the production and distribution of a COVID-19 vaccine — and for the Trump administration to lay out a distribution plan for a COVID-19 vaccine or vaccines no later than Aug. 7. Read More
Moderna’s potential COVID-19 vaccine generated neutralizing antibodies in patients, according to a phase 1 trial run by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Read More